Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
OP Bancorp
OPBK
$233M
| $608K | ﹤0.01% |
60,406
-30,377
| -33% | -$318K |
|
|
ONCT
3602
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $608K | ﹤0.01% |
6,403
+5,523
| +628% | +$655K |
|
3603
Edgewise Therapeutics
EWTX
$4.76B
| $607K | ﹤0.01% |
+28,473
| New | +$778K |
|
3604
Kinetik
KNTK
$4.31B
| $606K | ﹤0.01% |
+17,958
| New | +$568K |
|
|
PINE
3605
Alpine Income Property Trust
PINE
$347M
| $602K | ﹤0.01% |
31,657
-17,681
| -36% | -$324K |
|
3606
Solid Biosciences
SLDB
$1B
| $599K | ﹤0.01% |
10,912
+4,730
| +77% | +$312K |
|
|
EVBN
3607
DELISTED
Evans Bancorp Inc
EVBN
| $597K | ﹤0.01% |
16,076
-12,283
| -43% | -$448K |
|
|
CAJ
3608
DELISTED
Canon, Inc.
CAJ
| $597K | ﹤0.01% |
26,409
+381
| +1% | +$8.98K |
|
3609
Biglari Holdings Class B
BH
$1.21B
| $595K | ﹤0.01% |
3,732
-279
| -7% | -$42.9K |
|
3610
First United
FUNC
$294M
| $594K | ﹤0.01% |
34,074
-16,987
| -33% | -$306K |
|
|
KG
3611
Kestrel Group
KG
$61.7M
| $593K | ﹤0.01% |
+8,788
| New | +$611K |
|
|
FTCV
3612
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
| $592K | ﹤0.01% |
48,596
+12,912
| +36% | +$149K |
|
3613
First Business Financial Services
FBIZ
$595M
| $585K | ﹤0.01% |
21,642
-20,929
| -49% | -$552K |
|
3614
HF Foods Group
HFFG
$99.7M
| $584K | ﹤0.01% |
110,333
+1,031
| +0.9% | +$6.41K |
|
3615
Alerian MLP ETF
AMLP
$13.2B
| $583K | ﹤0.01% |
16,008
-65,616
| -80% | -$2.25M |
|
|
CDAK
3616
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $582K | ﹤0.01% |
31,404
+15,731
| +100% | +$302K |
|
|
OYST
3617
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $582K | ﹤0.01% |
33,861
+12,834
| +61% | +$244K |
|
|
VWTR
3618
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $582K | ﹤0.01% |
43,779
-57,752
| -57% | -$595K |
|
3619
Outlook Therapeutics
OTLK
$140M
| $578K | ﹤0.01% |
11,624
+6,865
| +144% | +$318K |
|
3620
Cognyte Software
CGNT
$673M
| $575K | ﹤0.01% |
23,448
-226,809
| -91% | -$5.61M |
|
3621
Information Services Group
III
$250M
| $570K | ﹤0.01% |
97,461
-20,084
| -17% | -$104K |
|
3622
WBI BullBear Value 3000 ETF
WBIF
$23.7M
| $566K | ﹤0.01% |
17,838
+948
| +6% | +$30.1K |
|
|
SOLY
3623
DELISTED
Soliton, Inc.
SOLY
| $565K | ﹤0.01% |
25,110
+3,746
| +18% | +$75.7K |
|
|
PRPH
3624
DELISTED
ProPhase Labs
PRPH
| $564K | ﹤0.01% |
9,109
| – | – |
|
3625
Eagle Bancorp Montana
EBMT
$186M
| $563K | ﹤0.01% |
24,497
-16,251
| -40% | -$386K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.